DOI QR코드

DOI QR Code

Investigation of Detected by Recent Various Human Papillomavirus from General Hospital in Seoul Area

최근 서울지역 종합병원에서 다양한 인유두종바이러스의 검출에 대한 실태조사

  • Lee, Jun-Beom (Department of Pathology, Gangnam CHA Hospital) ;
  • Park, Chang-Eun (Graduate School of Biomedical Laboratory Science, Namseoul University)
  • 이준범 (강남차병원 병리과) ;
  • 박창은 (남서울대학교 대학원 임상병리학과)
  • Received : 2016.07.31
  • Accepted : 2016.08.25
  • Published : 2016.09.30

Abstract

Human papillomavirus (HPV) infection is a necessary precondition of cervical cancer. A change from cytology to molecular HPV testing is, however, challenging. A new HPV DNA chip test for the infection of 22 HPV genotypes were developed in Korea. The purpose of this study was to investigate the prevalence and genotype distribution of HPV infection in the Seoul area. Over the last year, a total of 5,614 samples were tested. Using a chip test, HPV genotypes were detected in 1,596 (28.4%); of which, 679 (42.5%) were considered as high risk and low risk HPV were 152 (9.5%). 831 were single positive samples (n=1596). The most frequently found genotypes in all HPV-single positive samples (n=831) were HPV-16 (16.5%), 58 (15.2%), 52 (8.8%), 51 (7.1%) and 56 (5.9%). Mixed genotypes (n=219) were detected in 2 (n=176, 11.0%), 3 (n=37, 5.9%), and 4 (n=2, 0.1%) positive samples (n=1596). This study demonstrated that epidemical investigated HPV infection in patients of general hospital. These findings could be used to indicate a nationwide distribution of HPV and the adoption of vaccines. It is hoped that additional epidemiological research regarding the outcomes that are important to decision makers will be conducted.

인간 유두종 바이러스(HPV)에 의한 감염은 자궁경부암의 원인이다. HPV DNA의 세포 검사에서의 변화는 향후 더 도전적으로 발전을 기대한다, HPV 유전자형의 감염에 대한 새로운 HPV의 DNA(22종) chip 검사는 최근 한국에서 많이 개발되었다. 이 연구의 목적은 서울 지역에서 HPV 감염의 빈도와 유전자형 분포를 알아보고자 하였다. 지난 2015년 한 해 동안 서울지역 종합병원 내원객을 대상으로 총 5,614 검체의 검사에서 HPV 유전자형은 1,596 (28.4%)에서 검출되었다, 이중 한 종류의 유전자형은 가진 검체(n=831) 중고위험 HPV는 679 (42.5%), 저위험 HPV는 152 (9.5%)로 나타났다. 이중 자주 발견 유전자형은 HPV-16 (16.5%), 58 (15.2%), 52(8.8%), 51 (7.1%), 56 (5.9%) 순이었다. 혼합 유전자형(n=219) 중 2종(n=176, 11.0%), 3종(n=37, 5.9%), 4종(n=2, 0.1%)이 나타났다 이에 본 연구는 종합 병원 방문자의 HPV 감염을 조사하였다. 이러한 연구 결과는 HPV 전국적으로 분포 및 백신의 도입을 안내하는 데 이용될 수 있을 것으로 사료되며 진료에 중요한 정보를 제공하며 역학적 추가 연구가 요구된다.

Keywords

References

  1. zur Hausen H. Papillomaviruses in the causation of human cancers: a brief historical account. Virology. 2009;384:260-265. https://doi.org/10.1016/j.virol.2008.11.046
  2. Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16:1-17. https://doi.org/10.1128/CMR.16.1.1-17.2003
  3. Zheng ZM, Baker CC. Papillomavirus genome structure, expression, and posttranscriptional regulation. Front Biosci. 2006;11:2286-2302. https://doi.org/10.2741/1971
  4. Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113:18-25. https://doi.org/10.1097/AOG.0b013e31818f5008
  5. Mustafa RA, Santesso N, Khatib R, Mustafa AA, Wiercioch W, Kehar R, et al. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy. Int J Gynaecol Obstet. 2016;132:259-265. https://doi.org/10.1016/j.ijgo.2015.07.024
  6. Kim S, Lee IS, Lee D. Human papillomavirus prevalence and genotype distribution in normal and ASCUS specimens: comparison of a reverse blot hybridization assay with a DNA chip test. Biomed Sci Lett. 2015;21:32-39. https://doi.org/10.15616/BSL.2015.21.1.32
  7. Lee D, Kim G, Kim S, Park S, Wang HY, Park S, et al. Human papillomavirus distribution among women in Western Shandong province, East China using reverse blot hybridization assay. Biomed Sci Lett. 2015;21:69-76. https://doi.org/10.15616/BSL.2015.21.2.69
  8. Santesso N, Mustafa RA, Schunemann HJ, Arbyn M, Blumenthal PD, Cain J, et al. World Health Organization Guidelines: Treatment of cervical intraepithelial neoplasia 2-3 and screen and treat strategies to prevent cervical cancer. Int J Gynecol Obstet. 2016;132:252-258. https://doi.org/10.1016/j.ijgo.2015.07.038
  9. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110:525-541. https://doi.org/10.1042/CS20050369
  10. Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev. 1995;4:415-428.
  11. Dijkstra MG, Heideman DA, van Kemenade FJ, Hogewoning KJ, Hesselink AT, Verkuijten MC, et al. Brush based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN. J Clin Virol. 2012;54:147-151. https://doi.org/10.1016/j.jcv.2012.02.022
  12. Cobos C, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, et al. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol. 2014;33:383-401. https://doi.org/10.3109/08830185.2014.911857
  13. Sotlar K, Stubner A, Diemer D, Menton S, Menton M, Dietz K, et al. Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction. J Med Virol. 2004;74:107-116. https://doi.org/10.1002/jmv.20153
  14. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol. 2004;42:3176-3184. https://doi.org/10.1128/JCM.42.7.3176-3184.2004
  15. Hill CS. Molecular diagnostic testing for infectious diseases using TMA technology. Expert Rev Mol Diagn. 2001;1:445-455. https://doi.org/10.1586/14737159.1.4.445
  16. Nelson NC, Kacian DL. Chemiluminescent DNA probes: a comparison of the acridinium ester and dioxetane detection systems and their use in clinical diagnostic assays, Clin Chim Acta. 1990;194:73-90. https://doi.org/10.1016/0009-8981(90)90304-B
  17. Coutlee F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011;83:1034-1041. https://doi.org/10.1002/jmv.22081
  18. Thibaudeau E, Fortin B, Coutlee F, Nguyen-Tan P, Weng X, Audet ML, et al. HPV prevalence and prognostic value in a prospective cohort of 255 patients with locally advanced HNSCC: A single-centre experience. Int J Otolaryngol. 2013;2013:437815. doi: 10.1155/2013/437815.
  19. Suthipintawong C, Siriaunkgul S, Tungsinmunkong K, Pientong C, Ekalaksananan T, Karalak A, et al. Human papilloma virus prevalence, genotype distribution, and pattern of infection in Thai women. Asian Pac J Cancer Prev. 2011;12:853-856.
  20. Arbyn M, Snijders PJ, Meijer CJ, Berkhof J, Cuschieri K, Kocjan BJ, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect. 2015;21:817-826. https://doi.org/10.1016/j.cmi.2015.04.015
  21. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137:516-542. https://doi.org/10.1309/AJCPTGD94EVRSJCG
  22. Kroupis C, Vourlidis N. Human papilloma virus (HPV) molecular diagnostics. Clin Chem Lab Med. 2011;49:1783-1799.
  23. Rebolj M, Lynge E, Ejegod D, Preisler S, Rygaard C, Bonde J. Comparison of three human papillomavirus DNA assays and one mRNA assay in women with abnormal cytology. Gynecol Oncol. 2014;135:474-480. https://doi.org/10.1016/j.ygyno.2014.10.014
  24. Senkomago V, Des Marais AC, Rahangdale L, Vibat CR, Erlander MG, Smith JS. Comparison of urine specimen collection times and testing fractions for the detection of high-risk human papillomavirus and high-grade cervical precancer. J Clin Virol. 2016;74:26-31. https://doi.org/10.1016/j.jcv.2015.11.005
  25. Vorsters A, Van den Bergh J, Micalessi I, Biesmans S, Bogers J, Hens A, et al. Optimization of HPV DNA detection in urine by improving collection, storage, and extraction. Eur J Clin Microbiol Infect Dis. 2014;33:2005-2014. https://doi.org/10.1007/s10096-014-2147-2
  26. Chen J, Zhao KN. HPV-p53-miR-34a axis in HPV-associated cancers. Ann Transl Med. 2015;3:331. doi: 10.3978/j.issn.2305-5839.2015.09.39
  27. Lorincz AT, Brentnall AR, Scibior-Bentkowska D, Reuter C, Banwait R, Cadman L, et al. Validation of a DNA methylation HPV triage classifier in a screening sample. Int J Cancer. 2016;138:2745-2751. https://doi.org/10.1002/ijc.30008
  28. Boers A, Wang R, van Leeuwen RW, Klip HG, de Bock GH, Hollema H, et al. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. Clin Epigenetics. 2016;8:29. https://doi.org/10.1186/s13148-016-0196-3
  29. Lee YJ, Jung JH, Jung DY. The relationship between papanicolaou smear test and human papilloma virus DNA chip test in the uterine cervix. Korean J Clin Lab Sci. 2011;43:26-32.
  30. Lee KO, Seong HS, Chung SJ, Jung NY, Lee HJ, Kim KT. Genotype frequency of human papillomavirus determined by PCR and DNA sequencing in Korean women. Korean J Clin Lab Sci. 2006;38:99-104.
  31. Pereira N, Kucharczyk KM, Estes JL, Gerber RS, Lekovich JP, Elias RT, et al. Human papillomavirus infection, infertility, and assisted reproductive outcomes. J Pathog. 2015;2015:578423.
  32. Park MS, Cho HW, Kim JG, Bae NY, Oh DS, Park HH. Genotype analysis of human papilloma virus infection in accordance with cytological diagnoses. Korean J Clin Lab Sci. 2015;47:39-45. https://doi.org/10.15324/kjcls.2015.47.1.39
  33. Kim GH, Kim SH, Park SY, Park SJ, Lin H, Ren Y, et al. Human papillomavirus prevalence and distribution according to age among Korean and Chinese women. Korean J Clin Lab Sci. 2015;47:259-266. https://doi.org/10.15324/kjcls.2015.47.4.259

Cited by

  1. Analytical Performance of Sensitivity and Specificity for Rapid Multiplex High Risk Human Papillomavirus Detection Kit: HPV ViroCheck vol.49, pp.4, 2016, https://doi.org/10.15324/kjcls.2017.49.4.446
  2. 부산지역 여성의 자궁경부질환과 HPV의 상관관계 vol.51, pp.4, 2016, https://doi.org/10.15324/kjcls.2019.51.4.406